Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fimasartan/Atorvastatin Combination Tablet
NCT02566187Phase 1Completed
- Sponsor
- Boryung
- Start
- Aug 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fimasartan and atorvastatin in hypertension (HTN) and hyperlipidemia (2 arms), sponsored by Boryung. Primary endpoints: Maximum observed concentration and Area under the curve. Started Aug 2015; status: completed.
02
Drugs
fimasartanatorvastatin
03
Conditions
hypertension (HTN)hyperlipidemia
Beyond the preview
Go deeper on NCT02566187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02566187.